What is NDC 50102-211?

50102-211 is the product NDC for EContra One-Step (levonorgestrel), Levonorgestrel 1.5 mg/1 tablet, listed with the FDA by Afaxys Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

EContra One-Step (Levonorgestrel).

Afaxys Pharma, LLC, NDC labeler code 50102. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for EContra One-Step?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

EContra One-Step NDC 50102-211 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50102-211Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50102-0211Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50102-211-13	5010202111350102021113	3 CARTON in 1 PACKAGE (50102-211-13) / 1 BLISTER PACK in 1 CARTON (50102-211-11) / 1 TABLET in 1 BLISTER PACK (50102-211-01)Marketed from Oct 27, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): EContra One-Step
Generic name (nonproprietary): levonorgestrel
Active ingredients: Levonorgestrel — 1.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Afaxys Pharma, LLCNDC labeler code 50102
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206867
Marketing start: Feb 8, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 50102-211_d56023fd-6224-4727-bf3e-e5827dfe5f0aSPL ID d56023fd-6224-4727-bf3e-e5827dfe5f0aSPL set ID 94b23c49-dfba-4a70-ada5-e5c212e703c5RxCUI 483325, 1600602UNII 5W7SIA7YZW
Pharmacologic class: Progestin; Progestin-containing Intrauterine System

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450102021113 followed by a unit qualifier and the quantity

Package 50102-0211-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 8, 2025.

Indications (excerpt from the label)

Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50102-211

What is NDC 50102-211?: 50102-211 is the product NDC for EContra One-Step (levonorgestrel), Levonorgestrel 1.5 mg/1 tablet, listed with the FDA by Afaxys Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: EContra One-Step (Levonorgestrel).
What is the active ingredient?: Levonorgestrel.
Who is the labeler?: Afaxys Pharma, LLC, NDC labeler code 50102. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for EContra One-Step?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 206867

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206867
Product	Strength	Form · route	Labeler	Product NDC
After Bangerlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-891
Amazon Basic Care Levonorgestrellevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Amazon.com Services LLC	72288-324
Athentia Nextlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-721
Econ Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-841
Fem Choice morning afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-712
Ithappenz Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Aurohealth LLC	58602-892
Julielevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-532
Julielevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-538
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-002
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-003
Julie Morning After Pilllevonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Julie Products Inc.	82791-004
Levonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	Rugby Laboratories	0536-1433
Levonorgestrel	Levonorgestrel 1.5 mg/1	TabletOral	LEADER/ CARDINAL HEALTH 110, INC.	70000-0675
Morning Afterlevonorgestrel	Levonorgestrel 1.5 mg/1.5mg	TabletOral	Rapha Pharmaceuticals, Inc.	69953-515

EContra One-Step (Levonorgestrel) NDC 50102-211